Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Following a re-valuation of the cash element of the notional investment held within the US Retirement Savings Plan ("The Plan"), which is notionally held in GSK Ordinary share ADRs, the Administrators of the Plan notified GlaxoSmithKline plc and the under-mentioned person on 19 April 2011 of an increase in the notional allocation of Ordinary share ADRs on 15 April 2011 at a price of $41.13 per ADR:-
Director/PDMR
|
Connected Person |
Number of Shares |
||
Dr M M Slaoui
|
Dr K Slaoui |
4 |
||
|
|
|
||
This notification relates to a transaction notified in accordance with Disclosure and
Transparency Rule 3.1.4R(1)(c).
V A Whyte
Company Secretary
19 April 2011